Objectives: Fetal fibronectin (fFN) testing between the 24th and 34th weeks of pregnancy in patients with symptomatic preterm labor (PTL) helps assess the risk of spontaneous preterm birth (sPTB), yet ...
May 28, 2010 (San Francisco, California) — A new disposable measuring probe called CerviLenz, designed to measure vaginal cervical length, is as effective as fetal fibronectin in assessing risk for ...
A new diagnostic test offered earlier in pregnancy could help doctors determine if mothers-to-be are at risk of giving birth prematurely. The study was published in Obstetrics and Gynecology. In ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--April 28, 2005--Adeza (Nasdaq:ADZA) announced today that it has branded its proprietary test for fetal fibronectin (fFN) as FullTerm(TM), The Fetal Fibronectin Test ...
Expectant mothers, listen up. There is a simple test to detect a risk for premature birth. Dr Bruce Hensel has the exclusive story. "This is life saving information; because premature delivery raises ...
Lumos achieves first milestone in second phase of its development agreement to develop a new foetal fibronectin (fFN) test for Hologic, Inc. The fFN protein is found at the maternal-foetal interface ...
The diagnostics advisory committee considered evidence on the biomarker tests (PartoSure, Actim Partus and Rapid fetal fibronectin [fFN] 10Q Cassette Kit) for diagnosing preterm labour from several ...
Diagnostics is one of the key pillars of modern medicine. Diagnostics allows patients and doctors to identify a problem and even get ahead of it if caught early enough. Cancer diagnostics is an ...
There is a need to develop blood-based bioassays for breast cancer (BC) screening. In this study, differential gene expression between BC samples and benign tumours was used to identify candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results